Primary entity: MK-677 (Ibutamoren)Also known as: Ibutamoren; MK-0677; LUM-201; Nutrabol (folk)Class: performance-adjacent literacy (see page)Cluster: Performance-adjacent

MK-677 (ibutamoren) is an orally active growth hormone secretagogue that agonizes the ghrelin receptor (GHS-R1a), increasing endogenous GH and IGF-1 in studied settings — it is not a selective androgen receptor modulator. It is not a peptide, not FDA-approved as a consumer anti-aging or bodybuilding drug (developmental history includes discontinued Merck work and later Lumos LUM-201 programs for GH deficiency —), and is prohibited by WADA under S2.2.4 growth hormone secretagogues (not under the SARM/anabolic S1 section).

Important chemistry callout — MK-677 is NOT a SARM:

SARMs bind the androgen receptor. Ibutamoren binds the ghrelin / GH secretagogue receptor. USADA and FDA briefing materials explicitly note that MK-677 is often mislabeled as a SARM in online shops. Correct the class before any other comparison.

Regulatory / sport status at a glance (as of early Oct 2026):

No FDA-approved ibutamoren consumer product for bodybuilding/anti-aging. WADA: ibutamoren (MK-677) listed under S2.2.4 GHS/mimetics alongside agents such as ipamorelin and anamorelin — prohibited at all times. Some jurisdictions treat supply strictly; Sport Integrity Australia describes ibutamoren as prohibited and notes poison-scheduling themes.

Key takeaways

  • Not a SARM and not a peptide — oral GH secretagogue (ghrelin-receptor agonist).
  • ≠ Ostarine (MK-2866) — different MK code, different pharmacology.
  • Not FDA-approved for consumer physique/anti-aging use.
  • WADA S2.2.4 (GHS), not S1.2 SARMs
  • No dosage / “GH peaking” charts on this site.

Questions this page answers

Next questions we answer on this page (curiosity / AI-gap map):

  1. What is MK-677?
  2. Aliases / LUM-201
  3. Why shops call it a SARM
  4. What it is NOT
  5. Mechanism (ghrelin / GH)
  6. Evidence ladder
  7. What has been studied
  8. Safety literacy
  9. Regulatory & WADA
  10. Why no dosages
  11. Related (CJC / Ipamorelin)
  12. Who for / not for

Who is this profile for — and who is it not for?

For: readers who saw MK-677 in a “SARM stack” list and need the class correction, plus GH-axis adjacency to peptide secretagogues.

Not for: anyone seeking oral GH protocols, hunger-stack charts, or buy links.

What is MK-677?

Ibutamoren (MK-677 / MK-0677) is a spiropiperidine small molecule that mimics ghrelin at GHS-R1a, stimulating pituitary GH release and raising IGF-1 in clinical research contexts. Later development as LUM-201 targets pediatric GH deficiency pathways — that is a distinct regulated-development story, not permission for gray-market anti-aging use.

Adjacent peptide secretagogues: CJC-1295 / Ipamorelin.

Chemistry classOral GH secretagogue (GHS-R1a agonist)
Peptide?No
SARM?No
WADA sectionS2.2.4 GHS — (not S1.2)
MK confusion≠ MK-2866 (ostarine)

Also known as

  • Ibutamoren — drug name.
  • MK-677 / MK-0677 — Merck-era codes.
  • LUM-201 — Lumos development code for GH-deficiency programs
  • Nutrabol Online nickname — folk/vendor branding.
  • Mis-tags: “MK-677 SARM,” “ibutamoren peptide.”
Myth callout — “MK-677 is a SARM.”

False. Receptor: ghrelin/GHS-R1a, not AR. WADA files it under peptide hormones / growth factors / mimetics (S2), not other anabolic agents (S1.2). Shops that shelve it under SARMs are using retail taxonomy, not pharmacology.

How is MK-677 classified?

Investigational oral GHS / ghrelin mimetic — small molecule. Performance-adjacent + GH-axis literacy bridge to GHRP/GHRH peptide pages. Explicitly separated from the SARM set on this site.

What is MK-677 not?

MK-677 is not…Why that matters
A SARMDifferent receptor (GHS-R1a ≠ AR)
A peptideSmall-molecule secretagogue
Ostarine / MK-2866Different MK code and class
Injectable GHRaises endogenous GH/IGF-1 pathways; not recombinant GH vials
FDA-approved anti-aging pillNo such consumer approval
Something we doseRefusal

How is MK-677 thought to work?

Ghrelin-receptor agonism → GH pulse amplification → IGF-1 increases in studied human settings. Appetite (ghrelin-pathway) and metabolic effects appear in research narratives. Mechanism literacy ≠ approved indication.

What human vs animal vs label evidence exists?

Evidence typeWhat exists (summary)Maturity
Human clinical historicalMultiple clinical pharmacology / body-composition and GH-axis studies in various populations historicallyHuman Incomplete / not approved consumer label
Ongoing/related developmentLUM-201 GH-deficiency programsHuman Developmental
Approved U.S. consumer labelNone for ibutamoren bodybuilding/anti-agingNone
Forum sleep/hunger loreAnecdoteNone

This page does not invent IGF-1 percentage claims.

What has MK-677 been studied for?

GH/IGF-1 axis, body composition, aging-related and deficiency-related developmental themes historically. Recreational “oral GH” use is not an approved labeled use.

What safety topics come up?

Research and secondary literature discuss appetite increase, edema/water retention themes, insulin-sensitivity concerns, and cortisol/prolactin monitoring discussions in clinical contexts — not a home protocol. Long-term gray-market safety is unestablished. Not medical advice.

What is MK-677's regulatory status?

  • U.S.: No approved ibutamoren product for general anti-aging/bodybuilding. FDA PCAC materials have discussed ibutamoren in compounding contexts historically — recommendation ≠ approval
  • WADA: S2.2.4 growth hormone secretagogues — ibutamoren (MK-677) named
  • Mislabeling: Often sold in “SARM” bottles — class error with enforcement implications for athletes.

Why doesn't this page include a dosage chart?

“MK-677 dosage for height / anti-aging / recomp” queries are protocol-seeking. Refusal.

Related lab literacy

Oral small molecule — peptide reconstitution N/A. GH-axis peptide literacy: CJC-1295 / Ipamorelin.

Frequently asked questions

Is MK-677 a SARM?

No. It is a ghrelin-receptor agonist / GH secretagogue.

Is MK-677 a peptide?

No. It is a small molecule.

Is MK-677 the same as ostarine?

No. Ostarine is MK-2866, a SARM.

Where does WADA list it?

Under S2.2.4 growth hormone secretagogues — not S1.2 SARMs.

Is it FDA approved?

Not as an approved consumer anti-aging/bodybuilding drug.

Why no dosage chart?

YMYL refusal for unapproved endocrine self-experimentation.

Reminder

Not a SARM, not a peptide, WADA S2-relevant, not medical advice. Disclaimer..

Sources

The sources below were checked against PubMed, DailyMed, or the official agency page on November 10, 2026 (America/Phoenix). Links go to the publisher, PubMed, or the agency record.

  1. Primary — human Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008. doi:10.7326/0003-4819-149-9-200811040-00003. PMID: 18981485.
  2. Primary — human Adunsky A, Chandler J, Heyden N, et al. MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study. Arch Gerontol Geriatr. 2011. doi:10.1016/j.archger.2010.10.004. PMID: 21067829. The primary functional-performance analysis did not show a clear benefit versus placebo.
  3. Anti-doping World Anti-Doping Agency. The World Anti-Doping Code International Standard Prohibited List 2026. Accessed November 10, 2026. Confirm the current list and GlobalDRO before relying on sport status. The 2026 list names ibutamoren (MK-677) under S2 as a growth-hormone secretagogue. It is not a SARM.
Written by
Peptide Tutorials Staff — a group of independent researchers & writers (not clinicians)
Published · Updated
Oct 7, 2026 · Oct 7, 2026 · Regulatory and sport-status wording checked November 10, 2026 against current FDA labels and the 2026 WADA Prohibited List · How we source & update

Educational disclaimer: Educational only. MK-677 (ibutamoren) is not a SARM and not a peptide. Not FDA-approved for consumer physique use. No dosing or buy links. We don't sell peptides. Read our full disclaimers.